Flash Finance

Tarsons Products LimitedTARSONSCorporate

Medical Equipment & Supplies Latest results: Jun 2026 15 quarters of data
Consolidated Standalone
₹331.20
MCap ₹1,762 Cr · P/E 158.8
Tarsons Products Limited — Stock analysis & AI research Tarsons Products Limited — Multibagger AI analysis Tarsons Products Limited — Seasonality — best & worst months Tarsons Products Limited — Technical indicators & charts Tarsons Products Limited — Technical setup — score, trend, support & resistance Tarsons Products Limited — Live exchange announcements
📋 High Operating Margin Stocks 📈 MACD Bearish Crossover📈 Bollinger Squeeze Stocks📈 Bullish EMA Alignment📈 Volume Dry-Up Stocks📈 Multi-Timeframe Bullish Stocks📈 Accumulation (OBV Rising) 🏭 Healthcare sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹110 Cr
Sales · Jun 2026
+20.7% YoY
₹26 Cr
Operating Profit · Jun 2026
+5.2% YoY
23.6%
OPM % · Jun 2026
-12.6% YoY
₹-1 Cr
Net Profit · Jun 2026
-181.0% YoY
₹-0.27
EPS · Jun 2026
-179.4% YoY

📝 Tarsons Products Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Tarsons Products Limited reported revenue of ₹110 crore for the quarter ended June 2026 (Q1 FY27), up 20.7% from ₹91 crore in the same quarter last year, and down 8.8% sequentially over the March 2026 quarter.

The company reported a net loss of ₹1 crore, against a net profit of ₹2 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.27.

Operating profit stood at ₹26 crore — an operating margin (OPM) of 23.6%, compared with 27.0% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Tarsons Products Limited posted revenue of ₹423 crore, a decline of 66.3% over FY25, with a net profit of ₹14 crore (down 81.4% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹441 crore with a net profit of ₹11 crore.

Valuation snapshot

At the current price of ₹331.20, TARSONS has a market capitalisation of ₹1,762 crore and a trailing P/E of about 158.8.

Within the Medical Equipment & Supplies industry, it is the 2nd-largest of the 13 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 47.30%, foreign institutional investors (FIIs) 0.55%, domestic institutional investors (DIIs) 0.61%, public shareholders 51.53% of Tarsons Products Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹1,762 Cr
Current Price ?
₹331.2
P/E ?
158.78above ind
Industry P/E ?
26.90
P/B ?
2.78
P/S ?
3.99
P/FCF ?
-251.74
Enterprise Value ?
₹2,155 Cr
EV/EBITDA ?
18.08
PEG ?
N/A
Earnings Yield ?
0.7%
Dividend Yield ?
0.00%
Profitability & Returns
Sales (TTM) ?
₹441 Cr
OPM ?
27.0%
Profit after tax (TTM) ?
₹11 Cr
EPS (TTM) ?
₹2.09
ROCE ?
5.0%
ROE ?
1.7%
ROA ?
0.9%
Growth
Sales — latest qtr ?
₹110 Cr
PAT — latest qtr ?
₹-1 Cr
YoY qtr sales growth ?
20.7%
YoY qtr profit growth ?
-181.0%
Sales growth (3y) ?
N/A
Sales growth (5y) ?
13%
Profit growth (3y) ?
N/A
Profit growth (5y) ?
-26%
Financial Health
Debt ?
₹393 Cr
Debt to Equity ?
0.62
Interest Coverage ?
0.9
Current Ratio ?
N/A
Ownership
Promoter holding ?
47.30%
Change in promoter holding ?
-0.01%
Pledged percentage ?
N/A
Market
Return 3 months ?
15.2%
Return 6 months ?
54.7%

🗓️ Quarterly results (15 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best
Metric Sep 2021Dec 2021Mar 2022Dec 2022Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026 YoY % QoQ %
Sales 7671856162106859995711391102108121110 +20.7% -8.8%
Operating Profit 3833442723301925296372527323426 +5.2% -24.2%
Other Income 123333388436776 +79.2% -12.5%
Interest 2101344550555666 +23.5% +0.2%
Depreciation 557710121114174202022252927 +35.5% -7.1%
Profit Before Tax 34293922141761580163686-1 -143.7% -122.9%
Net Profit 25212916101041053102354-1 -181.0% -134.5%
EPS 4.894.045.543.031.871.940.751.930.991.920.340.620.950.79-0.27 -179.4% -134.2%
OPM % 50.6% 46.9% 52.2% 43.5% 37.0% 28.6% 22.1% 25.5% 31.0% 32.9% 27.0% 26.8% 29.2% 28.3% 23.6% -12.6% -16.6%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric FY25 FY26 TTM YoY %
Sales ₹1,254 Cr ₹423 Cr ₹441 Cr -66.3%
Operating Profit ₹377 Cr ₹118 Cr ₹119 Cr -68.8%
OPM % 30.11% 27.91% 27.01% -7.3%
NPM % 6.15% 3.39% 2.51% -44.9%
Other Income ₹24 Cr ₹23 Cr ₹26 Cr -2.4%
Depreciation ₹219 Cr ₹97 Cr ₹104 Cr -56.0%
Interest ₹65 Cr ₹23 Cr ₹24 Cr -65.1%
EBIT ₹158 Cr ₹21 Cr ₹16 Cr -86.5%
PBT ₹117 Cr ₹22 Cr ₹18 Cr -81.3%
Tax ₹40 Cr ₹4 Cr ₹2 Cr -91.2%
Net Profit ₹77 Cr ₹14 Cr ₹11 Cr -81.4%
EPS ₹5.59 ₹2.70 ₹2.09 -51.7%
Material Cost ₹408 Cr ₹54 Cr ₹63 Cr -86.7%
Employee Cost ₹213 Cr ₹36 Cr ₹39 Cr -83.2%
Extraordinary Items — — — —

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2022Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 11111111 +0.0%
Reserves 479602620624 +0.6%
Borrowings 22269339393 +15.9%
Other Liabilities 3390111158 +42.3%
Total Liabilities 5449721,0801,186 +9.8%
Fixed Assets 189336536733 +36.8%
CWIP 32267233159 -31.8%
Investments 0000 —
Other Assets 323369311295 -5.1%
Total Assets 5449721,0801,186 +9.8%

💧 Cash Flow (latest 4 periods)

Metric Mar 2022Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity 83103114118 +3.5%
Cash from Investing Activity -138-285-145-130 +10.3%
Cash from Financing Activity 130136399 -76.9%
Net Cash Flow 75-478-3 -137.5%
Free Cash Flow -48-81-37-7 +81.1%
CFO/OP 77%121%117%107% -8.5%

➗ Ratios (latest 4 periods)

Metric Mar 2022Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 79967474 +0.0%
Inventory Days 478572355341 -3.9%
Days Payable 75654453 +20.5%
Cash Conversion Cycle 482602385361 -6.2%
Working Capital Days 150-138-20 -152.6%
ROCE % 35%—7%5% -28.6%

👥 Shareholding (latest 6 periods)

Metric Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026 % Chg
Promoters 47.31%47.31%47.30%47.30%47.30%47.30% +0.0%
FIIs 9.14%5.82%2.46%0.87%0.16%0.55% +243.8%
DIIs 0.04%0.08%0.00%0.19%0.10%0.61% +510.0%
Public 43.50%46.79%50.23%51.65%52.44%51.53% -1.7%
No. of Shareholders 90,89188,96687,33684,09383,45380,867 -3.1%

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 13 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 FISCHER Fischer Medical ₹33.50 2,293 85.2 367 24 12.3% 6.7% 178.6% 2051.4% 249.4% -24.3%
2 TARSONS Tarsons Products ₹330.00 1,756 157.9 441 11 27.0% 2.5% -66.3% -81.4% 20.7% -181.0%
3 DENTALKART Vasa Denticity ₹563.10 977 80.0 299 12 4.4% 4.0% 16.7% -28.5% 12.9% -2.9%
4 543916 Hemant Surgical ₹193.85 544 13.9 231 18 10.4% 7.8% — — 187.9% 160.0%
5 543363 Prevest Denpro ₹616.50 456 32.8 75 23 35.7% 29.9% 13.6% 17.6% 23.7% 24.8%
6 QMSMEDI QMS Medical ₹185.89 359 52.7 162 7 13.1% 4.1% 5.1% -47.9% 23.7% -0.8%
7 NURECA Nureca ₹331.55 331 75.9 153 4 2.7% 2.8% 34.0% 146.7% 18.0% 277.2%
8 530427 Choksi Asia ₹65.64 122 7.2 47 5 14.5% 11.1% 61.1% 173.2% -22.5% -10.1%
9 527005 Shree Pacetronix ₹168.25 55 19.2 21 3 24.8% 15.3% 28.7% 324.3% -8.3% 14.5%
10 544143 Royal Sense ₹139.00 47 24.7 38 3 12.8% 8.0% — — 2.5% -5.4%
11 533212 GKB Ophthalmics ₹104.90 32 17.6 150 6 7.0% 3.7% 36.8% 142.7% 2.3% 388.5%
12 531380 Centenial Surgical ₹110.90 27 — 56 -1 10.7% -2.6% 0.6% -38.1% 18.6% 1937.8%
13 542765 Transpact Enterprises ₹325.00 4 140.1 0 0 63.2% 47.4% — — 12.5% -20.0%
❓ Frequently asked questions
What was Tarsons Products Limited's revenue in Q1 FY27?
Tarsons Products Limited reported revenue of ₹110 crore for the quarter ended June 2026 (Q1 FY27), up 20.7% from ₹91 crore in the same quarter last year, and down 8.8% sequentially over the March 2026 quarter.
What was Tarsons Products Limited's net profit in Q1 FY27?
The company reported a net loss of ₹1 crore, against a net profit of ₹2 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-0.27.
What is TARSONS's market capitalisation and P/E ratio?
At the current price of ₹331.20, TARSONS has a market capitalisation of ₹1,762 crore and a trailing P/E of about 158.8.
Who owns Tarsons Products Limited? (shareholding pattern)
As of Sep 2026, promoters held 47.30%, foreign institutional investors (FIIs) 0.55%, domestic institutional investors (DIIs) 0.61%, public shareholders 51.53% of Tarsons Products Limited.
TTM ends 2026-06-30. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI